Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × guadecitabine × Clear all

NCT03308396 2022-02-17

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms